Limitations and variability in cytoskeletal drug effects on protoplasts

Observed protoplast formation induced by cytoskeletal drugs (latrunculin B, CK-666, (-)-blebbistatin) was not reproducible in later trials, possibly due to fixation protocols, light exposure, media conditions, or other environmental factors, highlighting variability and unknown mediators in treatment response.

Part of Chain